SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading Statement

26 Jan 2021 07:00

RNS Number : 8095M
Forterra plc
26 January 2021
 

26 January 2021

FORTERRA PLC

TRADING STATEMENT

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update for the year ended 31 December 2020.

Current Trading & Year End Results

Our current priority remains ensuring the health, safety and wellbeing of our employees through the ongoing pandemic. Our factories remain open, operating in accordance with COVID-19 protocols, and we continue to supply our customers who, under current lockdown restrictions, remain fully operational.

We are pleased to report that the strong trading seen through September and October continued through to the end of the year, exceeding our expectations. Brick and Block revenues for November and December combined were 6% higher than the corresponding prior year period taking full year Group revenues to approximately £290m.

Accordingly, we expect to report 2020 EBITDA and PBT (both stated before exceptional items) of approximately £37m (an increase on our previous guidance of at least £34m) and £16m respectively.

We ended the year with a better than expected liquidity position with net cash of approximately £15m (stated before IFRS 16 lease liabilities) demonstrating our successful management of working capital but also reflecting some rephasing of payments on the Desford project. As at 31 December 2020 the Group had access to committed credit facilities of £170m of which £155m was undrawn.

Desford Brick Factory Construction

Project spend in 2020 amounted to £20m bringing the total to approximately £32m against the project budget of £95m. Following the previously reported insolvency of a major supplier, and after a comprehensive retendering and selection process, contracts for the supply and installation of the manufacturing equipment were signed in January. The planned commissioning of the factory remains on track for late 2022.

Outlook

Looking ahead, the steady improvement in trading through the second half of 2020, along with recent positive statements from our customers, provides growing cause for optimism, although uncertainty remains. The impact of the current Stamp Duty holiday coupled with the impending tapering of the Help to Buy scheme on underlying patterns of demand is unclear. Additionally, the wider economic implications of the UK's new trading relationship with the EU and the longer-term economic impact of the COVID-19 pandemic remain uncertain.

The Board continues to closely monitor both our markets and the wider economy and believes that the Group remains well-placed to benefit from a sustained recovery of our key markets with a structural under supply of housing in the UK expected to continue supporting long-term demand. In the shorter term, the strength of our balance sheet offers resilience against any further challenges ahead. 

We intend to issue our full year results announcement on 9 March 2021.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

ENQUIRIES

Forterra plc +44 1604 707 600

Stephen Harrison, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASFSAEAFEFA
Date   Source Headline
11th Jun 20262:52 pmRNSGrant under Long Term Incentive Plan
11th Jun 20267:00 amRNSDirectorate change
9th Jun 202611:53 amRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20269:45 amRNSTransaction in Own Shares
2nd Jun 202612:32 pmRNSEmployee Benefit Trust Share Purchase
2nd Jun 202612:30 pmRNSTotal Voting Rights and Capital
1st Jun 20267:00 amRNSAppointment of New Independent NED
27th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:03 pmRNSHolding(s) in Company
19th May 20264:41 pmRNSAnnual General Meeting 2026 Results
19th May 20267:01 amRNSTransaction in Own Shares
19th May 20267:00 amRNSAGM Trading Update
12th May 20261:32 pmRNSTransaction in Own Shares
12th May 20267:00 amRNSAGM RESOLUTION – APPROVAL OF REMUNERATION POLICY
7th May 20261:43 pmRNSHolding(s) in Company
6th May 202610:50 amRNSTransaction in Own Shares
6th May 20269:58 amRNSTotal Voting Rights and Capital
6th May 20269:55 amRNSEmployee Benefit Trust Share Purchase
28th Apr 202610:20 amRNSHolding(s) in Company
28th Apr 202610:18 amRNSTransaction in Own Shares
21st Apr 202611:31 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20265:40 pmRNSNotice of Annual General Meeting 2026
14th Apr 202610:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAppointment of new Independent NED
9th Apr 202610:15 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSDirector Declaration
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20262:07 pmRNSTotal Voting Rights
7th Apr 202612:47 pmRNSEmployee Benefit Trust Share Purchase
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20261:03 pmRNSDirector / PCA Shareholdings
25th Mar 202610:50 amRNSAnnual Report and Accounts 2025
24th Mar 202610:40 amRNSTransaction in Own Shares
24th Mar 20269:01 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSReplacement:Grant under Deferred Annual Bonus Plan
20th Mar 20268:45 amRNSGrant under Deferred Annual Bonus Plan
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 20263:27 pmRNSEmployee Benefit Trust Share Purchase
18th Feb 20262:27 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202612:26 pmRNSEmployee Benefit Trust Share Purchase
29th Jan 20268:33 amRNSHolding(s) in Company
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.